Search for a command to run...
SUMMARY Purpose: The main goal of our study was to study the Clinical significance of resistin in patients with ongoing dementia with eating disorders. Methods: 77 patients with dementia were studied. The average age of the research group was 78.0 ± 11.1 years. Dementia patients were divided into three groups: Group 1 - without eating disorders - n=19 (24.7%); Group 2 - eating disorders without dysphagia - n=28 (36.4%); Group 3 - eating disorders with dysphagia - n=30 (39.0%). The control group was made up of 22 people of the same age group who did not report dementia and/or eating disorders before participating in the study (average age - 73.8 ± 28.3 years). The degree of dementia was assessed by the MMSE, CDR and FAST scales. The presence of eating disorders was diagnosed with EdFED-Q and MNA-SF questionnaires. Eating disorders were observed in 58 patients (75.3%), and dysphagia in 30 (39.0%). Results: the results of the study showed that according to the MNA-SF scale, eating disorders in group 3 are more severe than in groups 1 and 2 (p<0.001, in both cases), and in group 2 - than in group 1 (p=0.003). The MMSE score in the dementia with dysphagia group is significantly lower than the other two groups. The mean MMSE score of patients without dysphagia but with eating disorders is significantly lower than the mean MMSE score of patients without eating disorders: In case of CDR questionnaire, dysphagia in dementia group compared to other 2 groups (p<0.001). CDR indicators of group 1 and group 2 did not differ from each other (p=0.100, NS). Conclusion: Eating disorders have a large and reliable impact on both the course of dementia and the metabolic characteristics of individuals with dementia. Among these disorders, a special place is occupied by dysphagia, which reliably worsens the degree of dementia and the levels of metabolites.